XHE Spdr S&P Health Care Equipment
- 84.440
- +0.630+0.75%
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
GainersSonoma Pharmaceuticals (NASDAQ:SNOA) shares rose 60.2% to $0.27 during Wednesday's pre-market session. The market value of their outstanding shares is at $4.2 million. As per the press release,
Silk Road Medical Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/18/2024 2.38% Lake Street $28 → $27.5 Downgrades Buy → Hold 05/01/2024 -21.82% JP Morgan $19 → $21 Main
Why Quantum Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Quantum Corporation (NASDAQ:QMCO) fell sharply during Tuesday's session after the company reported worse-than-expected FY24 financial results and issued FY25 guidance below estimates.Quantum
Patterson Companies, Silk Road Medical, Micron, Hewlett Packard Enterprise And Other Big Stocks Moving Higher On Tuesday
U.S. stocks were slightly higher, with the Dow Jones index gaining around 0.1% on Tuesday.Shares of Patterson Companies, Inc. (NASDAQ:PDCO) rose sharply during Tuesday's session following quarterly re
Boston Scientific Adds Stroke Prevention To Vascular Portfolio Via Silk Road Medical's $1.3B Deal
Tuesday, Boston Scientific Corporation (NYSE:BSX) agreed to acquire Silk Road Medical Inc (NASDAQ:SILK) for $27.50 in cash per share, representing an equity value of approximately $1.26 billion.The pe
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
GainersSonoma Pharmaceuticals (NASDAQ:SNOA) stock increased by 63.8% to $0.28 during Tuesday's pre-market session. The company's market cap stands at $4.3 million. As per the news, the Q4 earnings rep
Haemonetics' Strategic Moves Poised To Boost Margins And Earnings, Says Analyst
Needham & Co. analyst Mike Matson upgraded Haemonetics Corporation (NYSE:HAE) from Hold to Buy with a price target of $112.The analyst says that Haemonetics has reaffirmed its "high-20%" FY26 operatin
Soft Inflation Data Boosts Small Caps, Real Estate, Regional Banks; Traders Anticipate Fed Rate Cuts As Stocks React
A cooler-than-expected U.S. inflation report fueled a rally on Wall Street, ahead of the highly anticipated Federal Open Market Committee (FOMC) meeting at 2:00 p.m. Wednesday.What happened: Inflation
BTIG Upgrades Staar Surgical to Buy, Announces $46 Price Target
BTIG analyst Ryan Zimmerman upgrades Staar Surgical (NASDAQ:STAA) from Neutral to Buy and announces $46 price target.
Staar Surgical Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/11/2024 19.42% BTIG → $46 Upgrades Neutral → Buy 05/08/2024 — Needham Reiterates → Hold 05/08/2024 11.
Top 4 Health Care Stocks That May Keep You Up At Night This Month
As of June 11, 2024, four stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.The RSI is a momentum indicator
4 Constructive Medical Devices Stocks - BTIG
AMD To Rally Over 19%? Here Are 10 Top Analyst Forecasts For Monday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.Susquehanna
Stocks With the Highest and Lowest Liquidity - Goldman Sachs
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities.Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scan
TD Cowen Maintains Buy on TransMedics Gr, Raises Price Target to $175
TD Cowen analyst Joshua Jennings maintains TransMedics Gr (NASDAQ:TMDX) with a Buy and raises the price target from $130 to $175.
Stephens Starts TransMedic at Overweight, Cities Organ Transport Technology
A Closer Look at 7 Analyst Recommendations For NovoCure
7 analysts have shared their evaluations of NovoCure (NASDAQ:NVCR) during the recent three months, expressing a mix of bullish and bearish perspectives.The table below summarizes their recent ratings,
NovoCure Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/04/2024 -8.41% HC Wainwright & Co. $22 → $22 Reiterates Neutral → Neutral 05/02/2024 -8.41% HC Wainwrig
Stephens & Co. Initiates Coverage On TransMedics Gr With Overweight Rating, Announces Price Target of $151
Stephens & Co. analyst George Sellers initiates coverage on TransMedics Gr (NASDAQ:TMDX) with a Overweight rating and announces Price Target of $151.